Capital Group Investment Management PTE. LTD. Sells 5,235 Shares of CME Group Inc. $CME

Capital Group Investment Management PTE. LTD. lowered its stake in CME Group Inc. (NASDAQ:CME) by 62.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,082 shares of the financial services provider’s stock after selling 5,235 shares during the quarter. Capital Group Investment Management PTE. LTD.’s holdings in CME Group were worth $842,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. SG Americas Securities LLC grew its position in shares of CME Group by 345.2% during the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock worth $64,965,000 after purchasing an additional 184,459 shares in the last quarter. Dover Advisors LLC lifted its holdings in CME Group by 95.5% in the 3rd quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock worth $1,512,000 after purchasing an additional 2,734 shares in the last quarter. NEOS Investment Management LLC boosted its stake in CME Group by 32.5% in the 3rd quarter. NEOS Investment Management LLC now owns 50,977 shares of the financial services provider’s stock worth $13,773,000 after purchasing an additional 12,503 shares during the period. FLC Capital Advisors bought a new position in CME Group in the 4th quarter worth approximately $2,122,000. Finally, Lansforsakringar Fondforvaltning AB publ grew its holdings in CME Group by 1.6% during the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 114,411 shares of the financial services provider’s stock valued at $30,913,000 after buying an additional 1,777 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME opened at $257.40 on Monday. The business has a fifty day moving average of $288.35 and a 200 day moving average of $288.67. The stock has a market cap of $93.27 billion, a P/E ratio of 21.96, a PEG ratio of 2.88 and a beta of 0.21. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52-week low of $244.56 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.80 earnings per share. As a group, sell-side analysts anticipate that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

Analysts Set New Price Targets

Several research firms have recently issued reports on CME. Erste Group Bank cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. The Goldman Sachs Group decreased their target price on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. Weiss Ratings restated a “buy (a-)” rating on shares of CME Group in a report on Friday, May 29th. Finally, Argus reaffirmed a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $305.29.

Insider Activity at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 44,044 shares of company stock worth $13,297,507 in the last 90 days. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.